{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:50:08Z","timestamp":1754164208927,"version":"3.41.2"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Dermatol Surg","DS"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n            <jats:title>BACKGROUND<\/jats:title>\n            <jats:p>Lower extremity reticular and telangiectatic veins are of common cosmetic concern.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>OBJECTIVE<\/jats:title>\n            <jats:p>To retrospectively evaluate results of lower extremity sclerotherapy using a combination of foam and liquid sclerosing agents.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS<\/jats:title>\n            <jats:p>A retrospective chart review of sclerotherapy patients at a dermatology practice (January 2014 to April 2023) was performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>RESULTS<\/jats:title>\n            <jats:p>Eight hundred and nine patients (775 women and 34 men) with a mean age of 49.6 \u00b1 12.2 (18\u201384) years underwent a mean 1.4 \u00b1 0.7 (1\u20137) sessions. Multiple different sclerosing agents were used, with 0.2% sodium tetradecyl sulfate foam\/liquid predominating, although 72% glycerin liquid and 0.25% to 0.5% polidocanol foam\/liquid were also used. Coagula occurred in 61.0% of patients at 2 weeks and 6.4% at 3 months, whereas postsclerotherapy hyperpigmentation was seen in 5.0% and 19.1% of patients at the same time points. Both were more common after first-round treatment, each with a trend toward decreased frequency with increasing session number. Telangiectatic matting was found in 2.3% of 3-month follow-up patients. Edema, superficial venous thrombophlebitis, migraines, and ulceration were rarely seen. Significant clinical improvement was noted in 72.0% of treatments.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION<\/jats:title>\n            <jats:p>This retrospective chart review, the largest to date of its kind, confirms the safety and efficacy of cosmetic lower extremity sclerotherapy with a combination of foam and liquid sclerosing agents.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/dss.0000000000004273","type":"journal-article","created":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T11:30:16Z","timestamp":1718105416000},"page":"1034-1038","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Combination Foam and Liquid Sclerotherapy for Lower Extremity Reticular and Telangiectatic Veins: A Single-Center Retrospective Study"],"prefix":"10.1097","volume":"50","author":[{"given":"Kritin K.","family":"Verma","sequence":"first","affiliation":[{"name":"Texas Tech University Health Sciences Center, School of Medicine, Lubbock, Texas;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel P.","family":"Friedmann","sequence":"additional","affiliation":[{"name":"Westlake Dermatology Clinical Research Center, Westlake Dermatology & Cosmetic Surgery, Austin, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,6,11]]},"reference":[{"issue":"Suppl 2","key":"R2-20250731","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/j.1524-4725.2009.01469.x","article-title":"Sclerosants: a comparative review","volume":"36","author":"Duffy","year":"2010","journal-title":"Dermatol Surg"},{"issue":"Suppl 2","key":"R3-20250731","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/j.1524-4725.2010.01496.x","article-title":"Foam sclerotherapy for reticular veins and nontruncal varicose veins of the legs: a retrospective review of outcomes and adverse effects","volume":"36","author":"Palm","year":"2010","journal-title":"Dermatol Surg"},{"key":"R4-20250731","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1097\/DSS.0000000000003900","article-title":"Sclerotherapy off the lower extremities: a single-center retrospective study of veins treated on the dorsal hands and chest","volume":"49","author":"Verma","year":"2023","journal-title":"Dermatol Surg"},{"key":"R5-20250731","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0741-5214(03)00920-0","article-title":"Microthrombectomy reduces postsclerotherapy pigmentation: multicenter randomized trial","volume":"38","author":"Scultetus","year":"2003","journal-title":"J Vasc Surg"},{"key":"R6-20250731","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1524-4725.1995.tb00107.x","article-title":"Cutaneous necrosis, telangiectatic matting, and hyperpigmentation following sclerotherapy. Etiology, prevention, and treatment","volume":"21","author":"Goldman","year":"1995","journal-title":"Dermatol Surg"},{"key":"R7-20250731","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1097\/DSS.0000000000003465","article-title":"Sclerotherapy in aesthetic medicine: myths and realities","volume":"48","author":"Liu","year":"2022","journal-title":"Dermatol Surg"},{"key":"R8-20250731","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1524-4725.1990.tb00043.x","article-title":"Determination of incidence and risk factors for postsclerotherapy telangiectatic matting of the lower extremity: a retrospective analysis","volume":"16","author":"Davis","year":"1990","journal-title":"J Dermatol Surg Oncol"},{"key":"R9-20250731","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.sder.2006.12.009","article-title":"Complications of sclerotherapy","volume":"26","author":"Munavalli","year":"2007","journal-title":"Semin Cutan Med Surg"},{"issue":"Suppl 2","key":"R10-20250731","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1111\/j.1524-4725.2009.01408.x","article-title":"My sclerotherapy technique for telangiectasia and reticular veins","volume":"36","author":"Goldman","year":"2010","journal-title":"Dermatol Surg"},{"key":"R11-20250731","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/jdv.18639","article-title":"Skin hyperpigmentation after sclerotherapy with polidocanol: a systematic review","volume":"37","author":"Bossart","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R12-20250731","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/DSS.0000000000000225","article-title":"Consensus for sclerotherapy","volume":"40","author":"Weiss","year":"2014","journal-title":"Dermatol Surg"},{"key":"R13-20250731","first-page":"e42571","article-title":"Comparison of foam and liquid sclerotherapy for the treatment of lower extremity varicose veins and telangiectasia in obese patients","volume":"15","author":"Kanber","year":"2023","journal-title":"Cureus"},{"key":"R14-20250731","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1258\/phleb.2011.010073","article-title":"An investigation of side-effects and efficacy of foam-based sclerotherapy with carbon dioxide or room air in the treatment of reticular leg veins: a pilot study","volume":"27","author":"Peterson","year":"2012","journal-title":"Phlebology"},{"key":"R15-20250731","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/00042728-200506000-00003","article-title":"Double-blind prospective comparative trial between foamed and liquid polidocanol and sodium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins","volume":"31","author":"Rao","year":"2005","journal-title":"Dermatol Surg"},{"key":"R16-20250731","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1097\/DSS.0000000000000467","article-title":"A randomized, double-blind, placebo-controlled study of the effect of a high-potency topical corticosteroid after sclerotherapy for reticular and telangiectatic veins of the lower extremities","volume":"41","author":"Friedmann","year":"2015","journal-title":"Dermatol Surg"},{"key":"R17-20250731","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1097\/DSS.0000000000002709","article-title":"Comparison of the safety and efficacy of foam sclerotherapy with 1:2 polidocanol to air ratio versus 1:4 ratio for the treatment of reticular veins of the lower extremities","volume":"46","author":"Hoss","year":"2020","journal-title":"Dermatol Surg"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004273","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T22:02:01Z","timestamp":1753999321000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DSS.0000000000004273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,11]]},"references-count":16,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/dss.0000000000004273","relation":{},"ISSN":["1076-0512","1524-4725"],"issn-type":[{"type":"print","value":"1076-0512"},{"type":"electronic","value":"1524-4725"}],"subject":[],"published":{"date-parts":[[2024,6,11]]}}}